Drug Trial News

RSS
Measles and rubella vaccine delivered via microarray patch shows promising results

Measles and rubella vaccine delivered via microarray patch shows promising results

Majority of AI clinical trials report positive outcomes, yet concerns over generalizability persist

Majority of AI clinical trials report positive outcomes, yet concerns over generalizability persist

Single dose of malaria monoclonal antibody 77% effective in children, trial in Mali shows

Single dose of malaria monoclonal antibody 77% effective in children, trial in Mali shows

First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer

First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer

CASGEVY gene therapy eliminates vaso-occlusive crises in sickle cell patients

CASGEVY gene therapy eliminates vaso-occlusive crises in sickle cell patients

Novel immunotherapy shows promise for high-risk sarcomas: HEROS 2.0 trial results published

Novel immunotherapy shows promise for high-risk sarcomas: HEROS 2.0 trial results published

WOO Network trials investigate innovative treatments for liver, head and neck cancers

WOO Network trials investigate innovative treatments for liver, head and neck cancers

Phase 2 trial reveals Lixisenatide may reduce motor disability in Parkinson’s patients

Phase 2 trial reveals Lixisenatide may reduce motor disability in Parkinson’s patients

Phase 3 trial shows overall survival benefit from adjuvant therapy in kidney cancer patients

Phase 3 trial shows overall survival benefit from adjuvant therapy in kidney cancer patients

Vosoritide's first phase 2 study shows increased growth in children with hypochondroplasia

Vosoritide's first phase 2 study shows increased growth in children with hypochondroplasia

Home-administered nasal spray could be safely used to treat recurrent rapid heart rhythms

Home-administered nasal spray could be safely used to treat recurrent rapid heart rhythms

Personalized anti-tumor vaccine enhances immunotherapy for liver cancer

Personalized anti-tumor vaccine enhances immunotherapy for liver cancer

Ninerafaxstat shows good tolerability and safety in nonobstructive HCM patients

Ninerafaxstat shows good tolerability and safety in nonobstructive HCM patients

Treating early-stage heart failure in diabetic patients: Insights from ARISE-HF trial

Treating early-stage heart failure in diabetic patients: Insights from ARISE-HF trial

Investigational drug plozasiran shows promise in reducing severe hypertriglyceridemia

Investigational drug plozasiran shows promise in reducing severe hypertriglyceridemia

Novel combination therapy shows promise in difficult-to-treat endometrial cancer, study finds

Novel combination therapy shows promise in difficult-to-treat endometrial cancer, study finds

Clinical trial to test the feasibility of using at-home cancer immunotherapy

Clinical trial to test the feasibility of using at-home cancer immunotherapy

UC researchers open Phase 2 clinical trial to test new combination treatment for glioblastomas

UC researchers open Phase 2 clinical trial to test new combination treatment for glioblastomas

Minocycline fails to slow vision loss in people with dry age-related macular degeneration

Minocycline fails to slow vision loss in people with dry age-related macular degeneration

Investigational gene therapy shows promise for rare childhood neurodegenerative disease

Investigational gene therapy shows promise for rare childhood neurodegenerative disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.